Debra O. Adamo

459 total citations
8 papers, 359 citations indexed

About

Debra O. Adamo is a scholar working on Reproductive Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Debra O. Adamo has authored 8 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Reproductive Medicine, 4 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Debra O. Adamo's work include Ovarian cancer diagnosis and treatment (5 papers), Cancer Treatment and Pharmacology (4 papers) and Multiple Myeloma Research and Treatments (2 papers). Debra O. Adamo is often cited by papers focused on Ovarian cancer diagnosis and treatment (5 papers), Cancer Treatment and Pharmacology (4 papers) and Multiple Myeloma Research and Treatments (2 papers). Debra O. Adamo collaborates with scholars based in United States. Debra O. Adamo's co-authors include Elise C. Kohn, Gisele Sarosy, E Reed, Frederick P. Ognibene, Robert E. Cunnion, J Jacob, M.L. Rothenberg, David A. Stone, Patricia Anne Davis and Michaele C. Christian and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Debra O. Adamo

8 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Debra O. Adamo United States	6	253	123	76	51	48	8	359
I. Mandjes Netherlands	4	294 1.2×	32 0.3×	50 0.7×	33 0.6×	94 2.0×	4	408
C Villena-Heinsen Germany	14	132 0.5×	88 0.7×	55 0.7×	10 0.2×	124 2.6×	51	490
Lillian Pliner United States	11	149 0.6×	37 0.3×	54 0.7×	9 0.2×	157 3.3×	15	359
A. Athanassiades Greece	9	157 0.6×	27 0.2×	36 0.5×	19 0.4×	101 2.1×	11	398
M Steger United States	7	217 0.9×	139 1.1×	113 1.5×	8 0.2×	206 4.3×	8	477
Kyriaki Pliarchopoulou Greece	10	160 0.6×	58 0.5×	65 0.9×	10 0.2×	141 2.9×	14	351
David Edward Lebwohl United States	8	503 2.0×	19 0.2×	20 0.3×	151 3.0×	110 2.3×	11	686
Domenico Priolo Italy	6	169 0.7×	169 1.4×	97 1.3×	18 0.4×	92 1.9×	9	364
Angeles A. Alvarez United States	8	136 0.5×	188 1.5×	108 1.4×	8 0.2×	163 3.4×	11	405
Amelia Paglia Italy	9	129 0.5×	103 0.8×	128 1.7×	4 0.1×	144 3.0×	10	456

Countries citing papers authored by Debra O. Adamo

Since Specialization

Citations

This map shows the geographic impact of Debra O. Adamo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debra O. Adamo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debra O. Adamo more than expected).

Fields of papers citing papers by Debra O. Adamo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debra O. Adamo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debra O. Adamo. The network helps show where Debra O. Adamo may publish in the future.

Co-authorship network of co-authors of Debra O. Adamo

This figure shows the co-authorship network connecting the top 25 collaborators of Debra O. Adamo. A scholar is included among the top collaborators of Debra O. Adamo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debra O. Adamo. Debra O. Adamo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Bicher, Annette, Gisele Sarosy, Elise C. Kohn, et al.. (2010). Age does not influence taxol dose intensity in recurrent carcinoma of the ovary. Cancer. 71(S2). 594–600. 5 indexed citations

2.

Shapiro, Jeremy, Mace L. Rothenberg, Gisele Sarosy, et al.. (1998). Dose intensive combination platinum and cyclophosphamide in the treatment of patients with advanced untreated epithelial ovarian cancer. Cancer. 83(9). 1980–1988. 1 indexed citations

3.

Shapiro, Jeremy, M.L. Rothenberg, Gisele Sarosy, et al.. (1998). Dose intensive combination platinum and cyclophosphamide in the treatment of patients with advanced untreated epithelial ovarian cancer. Cancer. 83(9). 1980–1988. 17 indexed citations

4.

Link, Charles J., Gisele Sarosy, Elise C. Kohn, et al.. (1995). Cutaneous manifestations of taxol® therapy. Investigational New Drugs. 13(3). 261–263. 12 indexed citations

5.

Kohn, Elise C., Gisele Sarosy, Annette Bicher, et al.. (1994). Dose-Intense Taxol: High Response Rate in Patients With Platinum-Resistant Recurrent Ovarian Cancer. JNCI Journal of the National Cancer Institute. 86(1). 18–24. 152 indexed citations

6.

Bicher, Annette, Elise C. Kohn, Gisele Sarosy, et al.. (1993). The absence of cumulative bone marrow toxicity in patients with recurrent adenocarcinoma of the ovary receiving dose-intense taxol and granulocyte colony stimulating factor. Anti-Cancer Drugs. 4(2). 141–148. 8 indexed citations

7.

Sarosy, Gisele, Elise C. Kohn, David A. Stone, et al.. (1992). Phase I study of taxol and granulocyte colony-stimulating factor in patients with refractory ovarian cancer.. Journal of Clinical Oncology. 10(7). 1165–1170. 163 indexed citations

8.

Thomas, Rose V., et al.. (1990). New drug therapy for patients with HIV. Cancer Nursing. 13(5). 269???277–269???277. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact